The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes

The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys

Laura Helena Andrade, Jorge Javier Caraveo-Anduaga, Patricia A. Berglund et al. · International Journal of Methods in Psychiatric Research · 2003 · 1.1K citations · Full text

Medicine, Psychiatry, Behavioral Epidemiology +9

A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement

Andrew Mackinnon · Computers in Biology and Medicine · 2000 · 363 citations

Education, Biostatistics, Educational Assessment +11

Pharmacogenomics and Individualized Medicine: Translating Science Into Practice

Kristine R. Crews, J K Hicks, C-H Pui et al. · Clinical Pharmacology & Therapeutics · 2012 · 255 citations

Medicine, Pharmacology, Translational Sciences +16

CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine

Mohamed E. E. Shams, Borros Arneth, Christoph Hiemke et al. · Journal of Clinical Pharmacy and Therapeutics · 2006 · 243 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations

S P Myrand, Kanako Sekiguchi, MZ Man et al. · Clinical Pharmacology & Therapeutics · 2008 · 225 citations

Medicine, Pharmacokinetics, Pharmacology +17